Past, Present, and Future Drug Delivery Systems for Antiretrovirals

Adherence to medication.

Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974 · see citing works

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038 · see citing works

Structure and function of the blood–brain barrier

Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · see citing works

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096 · see citing works

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

Gallo, R. C., Salahuddin, S. Z., Popovič, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R. R., Oleske, J. M., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,639 · see citing works

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637 · see citing works

Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection

Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074 · see citing works

Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Samson, M., Libert, F., Doranz, B. J., Rucker, J. B., Liesnard, C., Farber, C., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,885 · see citing works

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435 · see citing works

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark‐Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953 · see citing works

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Gulick, R. M., Mellors, J. W., Havlir, D. V., Eron, J. J., Gonzalez, C. J., McMahon, D. K., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,883 · see citing works

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791 · see citing works

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

(2008) · The Lancet · doi:10.1016/s0140-6736(08)61113-7 · Cited by 1,661 · see citing works

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

Oberlin, E., Amara, A., Bachelerie, F., Chable-Bessia, C., Virelizier, J., Arenzana‐Seisdedos, F., Schwartz, O., Heard, J., Clark‐Lewis, I., Legler, D. F., et al. (1996) · Nature · doi:10.1038/382833a0 · Cited by 1,652 · see citing works

Preexposure Prophylaxis for HIV Infection among African Women

Damme, L. V., Corneli, A. L., Ahmed, K., Agot, K. E., Lombaard, J. J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R. N., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,605 · see citing works

Nanoparticle Delivery of Cancer Drugs

Wang, A. Z., Langer, R., & Farokhzad, O. C. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,575 · see citing works

Origins of HIV and the AIDS Pandemic

Sharp, P. M., & Hahn, B. H. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006841 · Cited by 1,496 · see citing works

Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery

Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · see citing works

Pneumocystis Pneumonia—Los Angeles

(1996) · JAMA · doi:10.1001/jama.1996.03540130018007 · Cited by 1,447 · see citing works

Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada

Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K. A., Burchell, A. N., Cohen, M. H., Gebo, K. A., Gill, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081355 · Cited by 1,420 · see citing works

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296 · see citing works

Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis

Bangalore, S., Kamalakkannan, G., Parkar, S., & Messerli, F. H. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.033 · Cited by 1,075 · see citing works

Sexual Transmission of HIV

Royce, R. A., Seña, A. C., Cates, W., & Cohen, M. S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361507 · Cited by 1,073 · see citing works

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

Kim, R. B., Fromm, M. F., Wandel, C., Leake, B. F., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054 · see citing works

Kaposis sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.

Friedman‐Kien, A. E., Laubenstein, L. J., Marmor, M. F., Hymes, K. B., Green, J., Ragaz, A., Gottleib, J., Muggia, F. M., Demopoulos, R. I., & Weintraub, M. R. (1981) · MMWR Morbidity and Mortality Weekly Report · Cited by 1,035 · see citing works

P-Glycoprotein, a gatekeeper in the blood–brain barrier

Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 968 · see citing works

Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein

Thomas, H., & Coley, H. M. (2003) · Cancer Control · doi:10.1177/107327480301000207 · Cited by 931 · see citing works

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4 + T Cells

Zhang, Z.-Q., Schuler, T., Zupancic, M., Wietgrefe, S. W., Staskus, K. A., Reimann, K. A., Reinhart, T. A., Rogan, M., Cavert, W. P., Miller, C. J., et al. (1999) · Science · doi:10.1126/science.286.5443.1353 · Cited by 873 · see citing works

HIV-1 Antiretroviral Drug TherapyPreprint

Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 856 · see citing works

Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1

Kowalski, M. M., Potz, J., Basiripour, L., Dorfman, T., Goh, W. C., Terwilliger, E. F., Dayton, A. I., Rosen, C. A., Haseltine, W. A., & Sodroski, J. (1987) · Science · doi:10.1126/science.3629244 · Cited by 848 · see citing works

HIV-Protease Inhibitors

Flexner, C. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381808 · Cited by 842 · see citing works

The Challenge of Finding a Cure for HIV Infection

Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D. J., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 840 · see citing works

Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System

Letendre, S. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 826 · see citing works

HIV-1 assembly, budding, and maturation

Sundquist, W. I., & Krausslich, H.-G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006924 · Cited by 814 · see citing works

Use of a vaginal ring containing dapivirine for HIV-1 prevention in women.

Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Matovu Kiweewa, F., Nair, G., Mhlanga, F., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506110 · Cited by 772 · see citing works

Factors Affecting Adherence to Antiretroviral Therapy

Chesney, M. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313849 · Cited by 703 · see citing works

Integrase inhibitors to treat HIV/Aids

Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature reviews. Drug discovery · doi:10.1038/nrd1660 · Cited by 693 · see citing works

Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues

Fletcher, C. V., Staskus, K. A., Wietgrefe, S. W., Rothenberger, M. K., Reilly, C., Chipman, J. G., Beilman, G. J., Khoruts, A., Thorkelson, A., Schmidt, T. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318249111 · Cited by 666 · see citing works

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

Gordillo, V. C., del Amo, J., Soriano, V., & González‐Lahoz, J. (1999) · AIDS · doi:10.1097/00002030-199909100-00021 · Cited by 657 · see citing works

Strategies in the design of antiviral drugs

Clercq, E. D. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 651 · see citing works

Pluronic® block copolymers for overcoming drug resistance in cancer

Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00047-9 · Cited by 637 · see citing works

Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1

Marlink, R., Kanki, P. J., Thior, I., Travers, K. U., Eisen, G., Siby, T., Traoré, I., Hsieh, C.-C., Dia, M., Gueye, E.-H., et al. (1994) · Science · doi:10.1126/science.7915856 · Cited by 634 · see citing works

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

De Clercq, E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.010 · Cited by 627 · see citing works

The Challenge of Viral Reservoirs in HIV-1 Infection

Blankson, J. N., Persaud, D., & Siliciano, R. F. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104024 · Cited by 623 · see citing works

Targeting early infection to prevent HIV-1 mucosal transmission

Haase, A. T. (2010) · Nature · doi:10.1038/nature08757 · Cited by 591 · see citing works

A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS?

Atkins, S. A., Lewin, S. A., Swart, T. M., & Volmink, J. A. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-104 · Cited by 564 · see citing works

Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV

Veronese, F. D. M., Copeland, T. D., DeVico, A. L., Rahman, R., Oroszlan, S. I., Gallo, R. C., & Sarngadharan, M. G. (1986) · Science · doi:10.1126/science.2418504 · Cited by 545 · see citing works

HIV-1 Protease Inhibitors Are Substrates for theMDR1 Multidrug Transporter

Lee, C. G. L., Gottesman, M. M., CARDARELLI, C. O., Ramachandra, M., Jeang, K., Ambudkar, S. V., Pastan, I. H., & Dey, S. (1998) · Biochemistry · doi:10.1021/bi972709x · Cited by 477 · see citing works

Association between Adherence to Antiretroviral Therapy and Human Immunodeficiency Virus Drug Resistance

Sethi, A. K., Celentano, D. D., Gange, S. J., Moore, R. D., & Gallant, J. E. (2003) · Clinical Infectious Diseases · doi:10.1086/378301 · Cited by 475 · see citing works

Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes

Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R. A., & Bolognesi, D. P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1331 · Cited by 466 · see citing works

Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons

Crum, N. F., Riffenburgh, R. H., Wegner, S. A., Agan, B. K., Tasker, S. A., Spooner, K., Armstrong, A. W., Fraser, S. L., & Wallace, M. R. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000179459.31562.16 · Cited by 456 · see citing works

AIDS — The First 20 Years

Sepkowitz, K. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442306 · Cited by 438 · see citing works

Expandable gastroretentive dosage forms

Klausner, E. A., Lavy, E., Friedman, M., & Hoffman, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00203-7 · Cited by 421 · see citing works

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)

de Béthune, M. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.008 · Cited by 406 · see citing works

Pharmacological Inhibition of P-glycoprotein Transport Enhances the Distribution of HIV-1 Protease Inhibitors into Brain and Testes

Choo, E. F., Leake, B. F., Wandel, C., Imamura, H., Wood, A. J. J., Wilkinson, G. R., & Kim, R. B. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15144-6 · Cited by 394 · see citing works

Challenges in the development of an HIV-1 vaccine

Barouch, D. H. (2008) · Nature · doi:10.1038/nature07352 · Cited by 379 · see citing works

Lipid solubility and drug penetration of the blood brain barrier

Oldendorf, W. H. (1974) · Experimental Biology and Medicine · doi:10.3181/00379727-147-38444 · Cited by 373 · see citing works

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

Baeten, J. M., Palanee‐Phillips, T., Brown, E. R., Schwartz, K. D., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Kiweewa, F. M., Nair, G., Mhlanga, F., et al. (2016) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000489577.60775.40 · Cited by 373 · see citing works

Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4 + T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans

Igarashi, T., Brown, C. R., Endo, Y., Buckler-White, A. J., Plishka, R. J., Bischofberger, N., Hirsch, V. M., & Martin, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.658 · Cited by 361 · see citing works

Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV.

(1992) · BMJ · doi:10.1136/bmj.304.6830.809 · Cited by 360 · see citing works

In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1 E )-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine)

Janssen, P. A. J., Lewi, P. J., Arnold, E., Daeyaert, F. F. D., de Jonge, M. R., Heeres, J., Koymans, L. M. H., Vinkers, M. H., Guillemont, J., Pasquier, E., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040840e · Cited by 348 · see citing works

Cellular Reservoirs of HIV-1 and their Role in Viral Persistence

Alexaki, A., Liu, Y., & Wigdahl, B. L. (2008) · Current HIV Research · doi:10.2174/157016208785861195 · Cited by 339 · see citing works

Current status and prospects of HIV treatment

Cihlář, T., & Fordyce, M. W. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.004 · Cited by 336 · see citing works

Past, present and future: 30 years of HIV research

Barré‐Sinoussi, F., Ross, A. L., & Delfraissy, J. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3132 · Cited by 333 · see citing works

Potential factors affecting adherence with HIV therapy

Mehta, S., Moore, R. D., & Graham, N. M. H. (1997) · AIDS · doi:10.1097/00002030-199714000-00002 · Cited by 332 · see citing works

A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices

Zhang, S., Bellinger, A. M., Glettig, D. L., Barman, R. A., Lee, Y. L., Zhu, J., Cleveland, C., Montgomery, V. A., Gu, L., Nash, L. D., et al. (2015) · Nature Materials · doi:10.1038/nmat4355 · Cited by 328 · see citing works

The Discovery of HIV as the Cause of AIDS

Gallo, R. C., & Montagnier, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038194 · Cited by 304 · see citing works

Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults

Ruane, P. J., DeJesus, E., Berger, D., Markowitz, M. H., Bredeek, U. F., Callebaut, C., Zhong, L., Ramanathan, S., Rhee, M. S., Fordyce, M. W., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182965d45 · Cited by 302 · see citing works

Cellular and Anatomical Reservoirs of HIV-1 in Patients Receiving Potent Antiretroviral Combination Therapy

Schrager, L. K. (1998) · JAMA · doi:10.1001/jama.280.1.67 · Cited by 301 · see citing works

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs

Coiras, M., López‐Huertas, M. R., Pérez‐Olmeda, M., & Alcamı́, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2223 · Cited by 281 · see citing works

Gels as vaginal drug delivery systems

das Neves, J., & Bahia, M. F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.012 · Cited by 253 · see citing works

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

Dou, H., Destache, C. J., Morehead, J., Mosley, R. L., Boska, M. D., Kingsley, J. D., Gorantla, S., Poluektova, L. Y., Nelson, J. A., Chaubal, M. V., et al. (2006) · Blood · doi:10.1182/blood-2006-03-012534 · Cited by 253 · see citing works

Condom Promotion for AIDS Prevention in the Developing World: Is It Working?

Hearst, N., & Chen, S. Y. (2004) · Studies in Family Planning · doi:10.1111/j.1728-4465.2004.00004.x · Cited by 248 · see citing works

Long-acting injectable antiretrovirals for HIV treatment and prevention

Spreen, W. R., Margolis, D. A., & Pottage, J. C. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000002 · Cited by 247 · see citing works

Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.

Kemper, E. M., van Zandbergen, A. E., Cleypool, C. G. J., Mos, H. A., Boogerd, W. J., Beijnen, J. H., & van Tellingen, O. (2003) · PubMed · Cited by 243 · see citing works

Structure and Function of HIV-1 Integrase

Chiu, T., & Davies, D. R. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043388547 · Cited by 242 · see citing works

Attitudes and Acceptance of Oral and Parenteral HIV Preexposure Prophylaxis among Potential User Groups: A Multinational Study

Eisingerich, A. B., Wheelock, A., Gomez, G. B., Garnett, G. P., Dybul, M. R., & Piot, P. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028238 · Cited by 238 · see citing works

Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS

Dou, H., Grotepas, C. B., McMillan, J., Destache, C. J., Chaubal, M. V., Werling, J. O., Kipp, J., Rabinow, B. E., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 238 · see citing works

Interventions to improve adherence to antiretroviral therapy

Chaiyachati, K. H., Ogbuoji, O., Price, M., Suthar, A. B., Negussie, E. K., & Bärnighausen, T. (2014) · AIDS · doi:10.1097/qad.0000000000000252 · Cited by 235 · see citing works

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment

Baert, L., Klooster, G. A. E. V. '., Dries, W., François, M., Wouters, A., Basstanie, E. D., Iterbeke, K., Stappers, F., Stevens, P., Schueller, L., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.03.006 · Cited by 224 · see citing works

Maraviroc: a review of its use in HIV infection and beyond

Kanmogne, G. D., & Woollard, S. M. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s90580 · Cited by 213 · see citing works

The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research

Varatharajan, L., & Thomas, S. A. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2008.12.013 · Cited by 207 · see citing works

Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

Granich, R., Crowley, S., Vitória, M., Smyth, C., Kahn, J. G., Bennett, R., Lo, Y.-R. J., Souteyrand, Y., & Williams, B. G. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833a6c32 · Cited by 200 · see citing works

The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance

Hsiou, Y., Ding, J., Das, K., Clark, A. D., Boyer, P. L., Lewi, P. J., Janssen, P. A. J., Kleim, J., Rösner, M., Hughes, S. H., et al. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4648 · Cited by 195 · see citing works

Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir

Aquaro, S., Caliò, R., Balzarini, J. M., Bellocchi, M. C., Garaci, E., & Perno, C. F. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00052-9 · Cited by 190 · see citing works

Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation

Klooster, G. A. E. V. '., Hoeben, E., Borghys, H., Looszova, A., Bouche, M.-P. L. A., Velsen, F. V., & Baert, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01529-09 · Cited by 186 · see citing works

Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir

Johnson, T. J., Gupta, K. M., Fabian, J., Albright, T. H., & Kiser, P. F. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.11.007 · Cited by 182 · see citing works

Formulation and pharmacology of long-acting cabotegravir

Trezza, C., Ford, S. L., Spreen, W., Pan, R., & Piscitelli, S. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000168 · Cited by 179 · see citing works

Advances in microbicide vaginal rings

Malcolm, K. R., Edwards, K.-L., Kiser, P. F., Romano, J., & Smith, T. J. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.09.003 · Cited by 172 · see citing works

Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis

Gunawardana, M., Remedios-Chan, M., Miller, C. S., Fanter, R. K., Yang, F., Marzinke, M. A., Hendrix, C. W., Béliveau, M., Moss, J. A., Smith, T. J., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00656-15 · Cited by 168 · see citing works

Vaginal Drug Delivery Systems for HIV Prevention

Rohan, L. C., & Sassi, A. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9082-7 · Cited by 168 · see citing works

Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings

Malcolm, K. R., Woolfson, A. D., Toner, C. F., Morrow, R. J., & McCullagh, S. D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki326 · Cited by 166 · see citing works

Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus

Andrews, C. D., Spreen, W. R., Mohri, H., Moss, L., Ford, S. L., Gettie, A., Russell‐Lodrigue, K., Bohm, R. P., Cheng‐Mayer, C., Hong, Z., et al. (2014) · Science · doi:10.1126/science.1248707 · Cited by 164 · see citing works

Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro

Bender, A. R., von Briesen, H., Kreuter, J., Duncan, I. B. R., & Rübsamen‐Waigmann, H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1467 · Cited by 155 · see citing works

Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide

Woolfson, A. D., Malcolm, K. R., Morrow, R. J., Toner, C. F., & McCullagh, S. D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.026 · Cited by 149 · see citing works

Safety and Pharmacokinetics of Dapivirine Delivery From Matrix and Reservoir Intravaginal Rings to HIV-Negative Women

Nel, A. M., Smythe, S. C., Young, K., Malcolm, K. R., McCoy, C. F., Rosenberg, Z., & Romano, J. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181acb536 · Cited by 148 · see citing works

Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting

Schäfer, V., von Briesen, H., Andreesen, R., Steffan, A.-M., Royer, C., Tröster, S., Kreuter, J., & Rübsamen-Waigmann, H. (1992) · Pharmaceutical Research · doi:10.1023/a:1015852732512 · Cited by 146 · see citing works

GSK1265744 Pharmacokinetics in Plasma and Tissue After Single-Dose Long-Acting Injectable Administration in Healthy Subjects

Spreen, W. R., Ford, S. L., Chen, S., Wilfret, D. A., Margolis, D. M., Gould, E. P., & Piscitelli, S. C. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000301 · Cited by 146 · see citing works

Adherence Support Approaches in Biomedical HIV Prevention Trials: Experiences, Insights and Future Directions from Four Multisite Prevention Trials

Amico, K. R., Mansoor, L. E., Corneli, A. L., Torjesen, K., & van der Straten, A. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0429-9 · Cited by 139 · see citing works

Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring

Romano, J., Variano, B., COPLAN, P. M., Roey, J. V., Douville, K. L., Rosenberg, Z., Temmerman, M., Verstraelen, H., Bortel, L. M. V., Weyers, S., et al. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0184 · Cited by 133 · see citing works

Entry inhibitors and their use in the treatment of HIV-1 infection

Haqqani, A. A., & Tilton, J. C. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.017 · Cited by 129 · see citing works

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice

Dash, P. K., Gendelman, H. E., Roy, U. B., Balkundi, S. S., Alnouti, Y., Mosley, R. L., Gelbard, H. A., McMillan, J., Gorantla, S., & Poluektova, L. Y. (2012) · AIDS · doi:10.1097/qad.0b013e328357f5ad · Cited by 126 · see citing works

NanoART Synthesis, Characterization, Uptake, Release and Toxicology for Human Monocyte–Macrophage Drug Delivery

Nowacek, A. S., Miller, R. L., McMillan, J., Kanmogne, G. D., Kanmogne, M., Mosley, R. L., Ma, Z., Graham, S., Chaubal, M. V., Werling, J. O., et al. (2009) · Nanomedicine · doi:10.2217/nnm.09.71 · Cited by 124 · see citing works

Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein

Kemper, E. M., Verheij, M., Boogerd, W. J., Beijnen, J. H., & van Tellingen, O. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.024 · Cited by 123 · see citing works

Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults

Spreen, W. R., Williams, P. E., Margolis, D. M., Ford, S. L., Crauwels, H. M., Lou, Y., Gould, E. P., Stevens, M., & Piscitelli, S. C. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000365 · Cited by 112 · see citing works

Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma

Antinori, A., Perno, C. F., Giancola, M. L., Forbici, F., Ippolito, G., Hoetelmans, R. M. W., & Piscitelli, S. C. (2005) · Clinical Infectious Diseases · doi:10.1086/498310 · Cited by 112 · see citing works

Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages

Nowacek, A. S., Balkundi, S. S., McMillan, J., Roy, U. B., Martinez-Skinner, A., Mosley, R. L., Kanmogne, G. D., Kabanov, A. V., Bronich, T. K., & Gendelman, H. E. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.019 · Cited by 110 · see citing works

The promise and pitfalls of long-acting injectable agents for HIV prevention

Landovitz, R. J., Kofron, R., & McCauley, M. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000219 · Cited by 110 · see citing works

Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats

Löbenberg, R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00105-3 · Cited by 109 · see citing works

A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis

Jackson, A., Else, L., Mesquita, P. M. M., Egan, D., Back, D. J., Karolia, Z., Ringner-Nackter, L., Higgs, C., Herold, B. C., Gazzard, B., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.118 · Cited by 106 · see citing works

Failure to Detect Nelfinavir in the Cerebrospinal Fluid of HIV-1-Infected Patients With and Without AIDS Dementia Complex

Aweeka, F. T., Jayewardene, A. L., Staprans, S. I., Bellibas, S. E., Kearney, B. P., Lizak, P. S., Novakovic-Agopian, T., & Price, R. W. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199901010-00006 · Cited by 102 · see citing works

Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy

Clark, J. T., Clark, M. R., Shelke, N. B., Johnson, T. J., Smith, E. M., Andreasen, A. K., Nebeker, J. S., Fabian, J., Friend, D. R., & Kiser, P. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088509 · Cited by 100 · see citing works

An Intravaginal Ring for the Simultaneous Delivery of Multiple Drugs

Baum, M. M., Butkyavichene, I., Gilman, J., Kennedy, S., Kopin, E. G., Malone, A. M. D., Nguyen, C., Smith, T. J., Friend, D. R., Clark, M. R., et al. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23208 · Cited by 99 · see citing works

Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes

Gagné, J.-F., Désormeaux, A., Perron, S., Tremblay, M. J., & Bergeron, M. G. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00432-1 · Cited by 97 · see citing works

Polyurethane Intravaginal Ring for Controlled Delivery of Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor of HIV-1

Gupta, K. M., Pearce, S. M., Poursaid, A. E., Aliyar, H. A., Tresco, P. A., Mitchnik, M. A., & Kiser, P. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21331 · Cited by 96 · see citing works

Barrier contraceptive use and HIV infection among high-risk women in Cameroon

Zekeng, L. A., Feldblum, P. J., Oliver, R. M., & Kaptué, L. (1993) · AIDS · doi:10.1097/00002030-199305000-00018 · Cited by 96 · see citing works

25 years of HIV

Fauci, A. S. (2008) · Nature · doi:10.1038/453289a · Cited by 96 · see citing works

A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge

Andrews, C. D., Yueh, Y. L., Spreen, W. R., Bernard, L. S., Boente-Carrera, M., Rodriguez, K., Gettie, A., Russell‐Lodrigue, K., Blanchard, J., Ford, S. L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010298 · Cited by 95 · see citing works

Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.

Magnani, M., Rossi, L., Brandi, G., Schiavano, G. F., Montroni, M., & Piedimonte, G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6477 · Cited by 95 · see citing works

The natural history of HIV-1 infection in Africa

Morgan, D., & Whitworth, J. A. G. (2001) · Nature Medicine · doi:10.1038/84564 · Cited by 91 · see citing works

Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages

Dou, H., Morehead, J., Destache, C. J., Kingsley, J. D., Shlyakhtenko, L. S., Zhou, Y., Chaubal, M. V., Werling, J. O., Kipp, J., Rabinow, B. E., et al. (2006) · Virology · doi:10.1016/j.virol.2006.08.012 · Cited by 90 · see citing works

Simultaneous Delivery of Tenofovir and Acyclovir via an Intravaginal Ring

Moss, J. A., Malone, A. M. D., Smith, T. J., Kennedy, S., Kopin, E. G., Nguyen, C., Gilman, J., Butkyavichene, I., Vincent, K. L., Motamedi, M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05662-11 · Cited by 89 · see citing works

Eradication of HIV-1 from the Macrophage Reservoir: An Uncertain Goal?

Abbas, W., Tariq, M., Iqbal, M., Kumar, A., & Herbein, G. (2015) · Viruses · doi:10.3390/v7041578 · Cited by 88 · see citing works

Lipid–Drug Association Enhanced HIV-1 Protease Inhibitor Indinavir Localization in Lymphoid Tissues and Viral Load Reduction: A Proof of Concept Study in HIV-2287-Infected Macaques

Kinman, L., Brodie, S. J., Tsai, C., Bui, T., Larsen, K., Schmidt, A. M., Anderson, D., Morton, W. R., Hu, S.-L., & Ho, R. J. Y. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200312010-00005 · Cited by 86 · see citing works

Anti-HIV Drug-Combination Nanoparticles Enhance Plasma Drug Exposure Duration as Well as Triple-Drug Combination Levels in Cells Within Lymph Nodes and Blood in Primates

Freeling, J. P., Koehn, J., Shu, C., Sun, J., & Ho, R. J. Y. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0210 · Cited by 85 · see citing works

Contraceptive vaginal rings: a review

Brache, V., & Faúndes, A. (2010) · Contraception · doi:10.1016/j.contraception.2010.04.012 · Cited by 82 · see citing works

The ins and outs of HIV replication

Gomez, C. Y., & Hope, T. J. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00516.x · Cited by 78 · see citing works

The role of lymphoid organs in the pathogenesis of HIV infection

Pantaleo, G., Graziosi, C., & Fauci, A. S. (1993) · Seminars in Immunology · doi:10.1006/smim.1993.1019 · Cited by 77 · see citing works

The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge

Radzio, J., Spreen, W. R., Yueh, Y. L., Mitchell, J. M., Jenkins, L. T., Garcia-Lerma, J. G., & Heneine, W. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010297 · Cited by 76 · see citing works

HIV-1 protease inhibitors and the MDR1 multidrug transporter.

Lee, C. G. L., & Gottesman, M. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2575 · Cited by 74 · see citing works

Perspective: Special delivery for the gut

Traverso, G. B., & Langer, R. (2015) · Nature · doi:10.1038/519s19a · Cited by 71 · see citing works

Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood

Freeling, J. P., Koehn, J., Shu, C., Sun, J., & Ho, R. J. Y. (2014) · AIDS · doi:10.1097/qad.0000000000000421 · Cited by 69 · see citing works

A Critical Subset Model Provides a Conceptual Basis for the High Antiviral Activity of Major HIV Drugs

Shen, L., Rabi, S. A., Sedaghat, A. R., Shan, L., Lai, J., Xing, S., & Siliciano, R. F. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002304 · Cited by 68 · see citing works

Targeting of 3′-Azido 3′-Deoxythymidine (AZT)-Loaded Poly(Isohexylcyanoacrylate) Nanospheres to the Gastrointestinal Mucosa and Associated Lymphoid Tissues

Dembri, A., Montisci, M., Gantier, J.-C., Chacun, H., & Ponchel, G. (2001) · Pharmaceutical Research · doi:10.1023/a:1011050209986 · Cited by 67 · see citing works

Novel Delivery System Enhances Efficacy of Antiretroviral Therapy in Animal Model for HIV-1 Encephalitis

Spitzenberger, T. J., Heilman, D., Diekmann, C., Batrakova, E. V., Kabanov, A. V., Gendelman, H. E., Elmquist, W. F., & Persidsky, Y. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600414 · Cited by 67 · see citing works

Pharmacodynamic and Antiretroviral Activities of Combination Nanoformulated Antiretrovirals in HIV-1–Infected Human Peripheral Blood Lymphocyte–Reconstituted Mice

Roy, U. B., McMillan, J., Alnouti, Y., Gautum, N., Smith, N. S., Balkundi, S. S., Dash, P. K., Gorantla, S., Martinez-Skinner, A., Meza, J. L., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis395 · Cited by 67 · see citing works

Macrophage Endocytic Trafficking of Antiretroviral Nanoparticles

Kadiu, I., Nowacek, A. S., McMillan, J., & Gendelman, H. E. (2011) · Nanomedicine · doi:10.2217/nnm.11.27 · Cited by 63 · see citing works

The development of novel HIV integrase inhibitors and the problem of drug resistance

Wainberg, M. A., Mésplède, T., & Quashie, P. K. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.08.007 · Cited by 60 · see citing works

An acceptability study of female-controlled methods of protection against HIV and STDs in south-western Uganda

Pool, R., WHITWORTH, J. A. G., Green, G., Mbonye, A. K., Harrison, S., Wilkinson, J., & Hart, G. J. (2000) · International Journal of STD & AIDS · doi:10.1258/0956462001915606 · Cited by 59 · see citing works

An analysis of FDA-approved drugs for infectious disease: HIV/AIDS drugs

Kinch, M. S., & Patridge, E. V. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.05.012 · Cited by 59 · see citing works

Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.

Saksena, N. K., & Potter, S. J. (2003) · PubMed · Cited by 56 · see citing works

Long-acting HIV drugs advanced to overcome adherence challenge

Dolgin, E. (2014) · Nature Medicine · doi:10.1038/nm0414-323 · Cited by 56 · see citing works

New delivery systems in contraception: vaginal rings

Johansson, E. D. B., & Sitruk-Ware, R. L. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.056 · Cited by 54 · see citing works

Preexposure Prophylaxis for HIV Prevention

Kelesidis, T., & Landovitz, R. J. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0078-4 · Cited by 53 · see citing works

Safe and Sustained Vaginal Delivery of Pyrimidinedione HIV-1 Inhibitors from Polyurethane Intravaginal Rings

Johnson, T. J., Srinivasan, P., Albright, T. H., Buckheit, K. W., Rabe, L. K., Martin, A. M., Pau, C., Hendry, R. M., Otten, R. A., McNicholl, J. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05721-11 · Cited by 52 · see citing works

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations

Gendelman, H. E., Balkundi, Nowacek, Veerhubhotla, Chen, Martinez-Skinner, Roy, U. B., Mosley, Kanmogne, Kabanov, A. V., et al. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s27830 · Cited by 51 · see citing works

The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy

Ross, E. L., Weinstein, M. C., Schackman, B. R., Sax, P. E., Paltiel, A. D., Walensky, R. P., Freedberg, K. A., & Losina, E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1159 · Cited by 51 · see citing works

Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection

Weissman, D., & Fauci, A. S. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.2.358 · Cited by 49 · see citing works

Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir

Clark, J. T., Johnson, T. J., Clark, M. R., Nebeker, J. S., Fabian, J., Tuitupou, A. L., Ponnapalli, S., Smith, E. M., Friend, D. R., & Kiser, P. F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.033 · Cited by 44 · see citing works

Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus

Rossi, L. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.6.819 · Cited by 44 · see citing works

Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats

Savolainen, J., Edwards, J. E., Morgan, M. E., McNamara, P. J., & Anderson, B. D. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.479 · Cited by 43 · see citing works

An Evaluation of Intravaginal Rings as a Potential HIV Prevention Device in Urban Kenya: Behaviors and Attitudes That Might Influence Uptake within a High-Risk Population

Smith, D. J., Wakasiaka, S., Hoang, T. D. M., Bwayo, J. J., del Rı́o, C., & Priddy, F. H. (2008) · Journal of Women s Health · doi:10.1089/jwh.2007.0529 · Cited by 42 · see citing works

Long-acting rilpivirine for HIV prevention

Jackson, A., & McGowan, I. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000160 · Cited by 42 · see citing works

Effects of Physiological Fluids on Physical-Chemical Characteristics and Activity of Topical Vaginal Microbicide Products

Sassi, A. B., Isaacs, C. E., Moncla, B. J., Gupta, P., Hillier, S. L., & Rohan, L. C. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21192 · Cited by 40 · see citing works

Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1

Bestman‐Smith, J., Gourde, P., Désormeaux, A., Tremblay, M. J., & Bergeron, M. G. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00254-6 · Cited by 40 · see citing works

Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs

Morgan, M. E., Chi, S. C., Murakami, K., Mitsuya, H., & Anderson, B. D. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.10.2156 · Cited by 37 · see citing works

Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection

McConville, C., Boyd, P., & Major, I. (2014) · Clinical Medicine Insights Women s Health · doi:10.4137/cmwh.s10353 · Cited by 37 · see citing works

Engineering a degradable polyurethane intravaginal ring for sustained delivery of dapivirine

Kaur, M., Gupta, K. M., Poursaid, A. E., Karra, P., Mahalingam, A., Aliyar, H. A., & Kiser, P. F. (2011) · Drug Delivery and Translational Research · doi:10.1007/s13346-011-0027-1 · Cited by 35 · see citing works

A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges

Kovářová, M., Swanson, M. D., Sánchez, R. I., Baker, C., Steve, J., Spagnuolo, R. A., Howell, B. J., Hazuda, D. J., & Garcia, J. V. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw042 · Cited by 35 · see citing works

Tipranavir: A New Option for the Treatment of Drug-Resistant HIV Infection

Saravolatz, L. D., Temesgen, Z., & Feinberg, J. (2007) · Clinical Infectious Diseases · doi:10.1086/520847 · Cited by 34 · see citing works

Nanodrug Formulations to Enhance HIV Drug Exposure in Lymphoid Tissues and Cells: Clinical Significance and Potential Impact on Treatment and Eradication of HIV/AIDS

Shao, J., Kraft, J. C., Li, B., Yu, J., Freeling, J. P., Koehn, J., & Ho, R. J. Y. (2016) · Nanomedicine · doi:10.2217/nnm.16.1 · Cited by 34 · see citing works

Potential Use of Vaginal Rings for Prevention of Heterosexual Transmission of HIV

Woolfson, A. D., Malcolm, K. R., Toner, C. F., Morrow, R. J., Lowry, D., Jamil, A., & McCullagh, S. D. (2006) · American Journal of Drug Delivery · doi:10.2165/00137696-200604010-00002 · Cited by 32 · see citing works

Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy

Bell, S. E. J., Dennis, A. C., Fido, L. A., Malcolm, K. R., Sirimuthu, N. M. S., Toner, C. F., & Woolfson, A. D. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.2.0007 · Cited by 23 · see citing works

An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission

Ugaonkar, S. R., Clark, J. T., English, L. B., Johnson, T. J., Buckheit, K. W., Bahde, R. J., Appella, D. H., Buckheit, R. W., & Kiser, P. F. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24551 · Cited by 23 · see citing works

Targeted drug delivery to the brain via phosphonate derivatives II. Anionic chemical delivery system for zidovudine (AZT)

Somogyi, G., Buchwald, P., Nomi, D., Prókai, L., & Bodor, N. S. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00012-x · Cited by 22 · see citing works

A novel approach to administration of peptides in women: Systemic absorption of a GnRH agonist via transvaginal ring delivery system

Kimball, A. B., Javorsky, E., Ron, E., Crowley, W. F., & Langer, R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.035 · Cited by 22 · see citing works

Pharmacokinetics of Injectable, Long-Acting Nevirapine for HIV Prophylaxis in Breastfeeding Infants

Cortez, J. M., Quintero, R., Moss, J. A., Béliveau, M., Smith, T. J., & Baum, M. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03906-14 · Cited by 20 · see citing works

Ingress of blood-borne macrophages across the blood-brain barrier in murine HIV-1 encephalitis

Liu, Y., Uberti, M., Dou, H., Banerjee, R., Grotepas, C. B., Stone, D. K., Rabinow, B. E., Gendelman, H. E., & Boska, M. D. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.009 · Cited by 19 · see citing works

The search for antiviral drugs: case histories from concept to clinic.

Adams, J., & Merluzzi, V. J. (1993) · Birkhäuser Boston eBooks · Cited by 16 · see citing works

Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro

N’Da, D. D., & Breytenbach, J. C. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.06.0004 · Cited by 15 · see citing works

Controlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral release

Teller, R. S., Malaspina, D. C., Rastogi, R., Clark, J. T., Szleifer, I. G., & Kiser, P. F. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.035 · Cited by 15 · see citing works

Influence of HIV-infection on the phagocytic activity of monocytes/macrophages and granulocytes

Schäfer, V., Kreuter, J., Rübsamen‐Waigmann, H., Gerte, S., & von Briesen, H. (1994) · Clinical and Diagnostic Virology · doi:10.1016/0928-0197(94)90058-2 · Cited by 12 · see citing works

Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro

N’Da, D. D., & Breytenbach, J. C. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp/61.06.0004 · Cited by 7 · see citing works

Discovery and Development of Zidovudine as the Cornerstone of Therapy to Control Human Immunodeficiency Virus Infection

Pattishall, K. H. (1993) · The Search for Antiviral Drugs · doi:10.1007/978-1-4899-6718-3_2 · Cited by 6 · cited 10× · see citing works

A Bid to Thwart HIV With Shot of Long-Lasting Drug

Cohen, J. D. (2014) · Science · doi:10.1126/science.343.6175.1067 · Cited by 4 · see citing works

Maraviroc first-line therapy for HIV infection. Too risky.

(2010) · PubMed · Cited by 1 · see citing works

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520 · see citing works

Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy

Kirtane, A. R., Abouzid, O., Minahan, D., Bensel, T., Hill, A. L., Selinger, C., Bershteyn, A., Craig, M., Mo, S. S., Mazdiyasni, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02294-6 · Cited by 227 · see citing works

Can Antiretroviral Drugs Be Used to Treat Porcine Endogenous Retrovirus (PERV) Infection after Xenotransplantation?

Denner, J. (2017) · Viruses · doi:10.3390/v9080213 · Cited by 60 · see citing works

A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment

Verma, M., Vishwanath, K., Eweje, F. R., Roxhed, N., Grant, T. M., Castaneda, M., Steiger, C., Mazdiyasni, H., Bensel, T., Minahan, D. J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6267 · Cited by 53 · see citing works

Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution

Kevadiya, B. D., Woldstad, C., Ottemann, B. M., Dash, P. K., Sajja, B. R., Lamberty, B. G., Morsey, B., Kocher, T., Dutta, R., Bade, A. N., et al. (2017) · Theranostics · doi:10.7150/thno.22764 · Cited by 51 · see citing works

Treatment and prevention of HIV infection with long-acting antiretrovirals

Benítez‐Gutiérrez, L., Soriano, V., Requena, S., Arias, A., Barreiro, P., & de Mendoza, C. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1453805 · Cited by 50 · see citing works

Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques

McMillan, J., Szlachetka, A., Slack, L., Sillman, B., Lamberty, B., Morsey, B., Callen, S., Gautam, N., Alnouti, Y., Edagwa, B., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01316-17 · Cited by 32 · see citing works

Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking

Mukadam, I. Z., Machhi, J., Herskovitz, J., Hasan, M., Oleynikov, M. D., Blomberg, W. R., Svechkarev, D. A., Mohs, A. M., Zhou, Y., Dash, P. K., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119669 · Cited by 27 · see citing works

Seeing Is Believing: Nuclear Imaging of HIV Persistence

Henrich, T. J., Hsue, P. Y., & VanBrocklin, H. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02077 · Cited by 22 · see citing works

Synthesis of a long acting nanoformulated emtricitabine ProTide

Soni, D., Bade, A. N., Gautam, N., Herskovitz, J., Ibrahim, I. M., Smith, N. A., Wojtkiewicz, M. S., Shetty, B. L. D., Alnouti, Y., McMillan, J., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119441 · Cited by 21 · see citing works

Phenylboronic Acid-conjugated Exosomes for Enhanced Anticancer Therapeutic Effect by Increasing Doxorubicin Loading Efficiency

Kim, H., Kang, S. J., & Rhee, W. J. (2021) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-020-0107-5 · Cited by 17 · see citing works

Exosome-based antisense locked nucleic acid delivery for inhibition of type II collagen degradation in chondrocyte

Jeong, K., Jeong, S.-A., Kim, J. A., & Rhee, W. J. (2019) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2019.02.017 · Cited by 15 · see citing works

Convergence for Translation: Drug‐Delivery Research in Multidisciplinary Teams

Traverso, G., Kirtane, A. R., Schoellhammer, C. M., & Langer, R. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712512 · Cited by 13 · see citing works

Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice

McMillan, J., Cobb, D. A., Lin, Z., Banoub, M. G., Dagur, R. S., Woods, A. B., Wang, W., Makarov, E., Kocher, T., Joshi, P. S., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.247288 · Cited by 12 · see citing works

An Overview of Antiretroviral Agents for Treating HIV Infection in Paediatric Population

Melo, R., Lemos, A., Preto, A. J., Bueschbell, B., Matos‐Filipe, P., Barreto, C. A. V., de Almeida, J. G., Silva, R. D. M., Correia, J. D. G., & Moreira, I. S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180904123549 · Cited by 11 · see citing works

Behavioral and Physical Activity Interventions for HAND

Montoya, J. L., Henry, B., & Moore, D. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_79 · Cited by 7 · see citing works

USE OF NANOTECHNOLOGY TO MITIGATE ANTIMICROBIAL RESISTANCE

Muhammad Ifham Naeem ¹, *., ², A. R., ³, R. Z., ³, U. T., ³, Z. A., ¹, S. A., ¹, T. A., 4, H. M. A., 4, M. R. U., ⁴, Q. A., et al. (2023) · Agrobiological Records · doi:10.47278/journal.abr/2023.020 · Cited by 10 · see citing works

Bionanotechnology and bioMEMS (BNM): state-of-the-art applications, opportunities, and challenges

Borenstein, J. T., Cummins, G., Dutta, A., Hamad, E. M., Hughes, M. P., Jiang, X., Lee, H., Lei, K. F., Tang, X. S., Zheng, Y., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00296a · Cited by 8 · see citing works

Evaluation of Vaginal Drug Levels and Safety of a Locally Administered Glycerol Monolaurate Cream in Rhesus Macaques

Kirtane, A. R., Rothenberger, M. K., Frieberg, A., Nephew, K. R., SCHULTZ‐DARKEN, N. J., Schmidt, T. E., Reimann, T. G., Haase, A. T., & Panyam, J. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.03.030 · Cited by 7 · see citing works

Long-acting antiretroviral therapy in low-income and middle-income countries: considerations for roll-out

Tembo, A., Venter, F., & Sokhela, S. M. (2024) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000900 · Cited by 6 · see citing works

Reasons for antiretroviral switching in Colombia: A retrospective cohort study

Valderrama, S., Martínez-Vernaza, S., Forero, S. V. C., Jaimes-Reyes, M. A., Arévalo-Mora, L., Martínez, E., Franco, J., Beltrán-Rodríguez, C., Urrego-Reyes, J., Leon, S., et al. (2023) · International Journal of STD & AIDS · doi:10.1177/09564624231181156 · Cited by 4 · see citing works

Biotechnological Approaches in Infectious Diseases

Banerjee, S., Bose, S., Shukla, A. C., & Baig, M. R. (2024) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-97-1148-2_15 · Cited by 3 · see citing works

Translation durch Konvergenz: Drug‐Delivery‐Forschung in multidisziplinären Teams

Traverso, G., Kirtane, A. R., Schoellhammer, C. M., & Langer, R. (2018) · Angewandte Chemie · doi:10.1002/ange.201712512 · Cited by 2 · see citing works

Getting Treatment and Care Services Right for Children and Adolescents to Reach High Viral Suppression

Penazzato, M., Sugandhi, N., Essajee, S. M., Doherty, M. C., Ficht, A., & Phelps, B. R. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001738 · Cited by 2 · see citing works

Infectious Risk and Protection

Kim, C. (2024) · Springer eBooks · doi:10.1007/978-981-99-7691-1_21 · Cited by 1 · see citing works

Is pharmacological eradication of HIV possible?

Snopková, S., Husa, P., & Kozáková, Š. (2022) · Klinická farmakologie a farmacie · doi:10.36290/far.2022.015

Role of Artificial Neural Networks in Optimizing Bioconversion of Antiretroviral Drugs: A Review

Tsotetsi, N. T., Rasifudi, N. F., Magage, B., & Mekuto, L. (2026) · BioMedInformatics · doi:10.3390/biomedinformatics6030030

An ingestible origami-inspired metamaterial for prolonged oral delivery of therapeutics

Javid, F., Babaee, S., Quigley, J., Kirtane, A. R., Mazdiyasni, H., Rogner, J., Cleveland, C., Bensel, T., Soares, V. V., Collins, J. E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76028-y

Novel Antiretroviral Therapeutic Strategies for HIV

Cunha, R. F., Simões, S., Carvalheiro, M., Azevedo‐Pereira, J. M., Santos‐Costa, Q., & Ascenso, A. (2021) · Molecules · doi:10.3390/molecules26175305 · Cited by 37 · see citing works

Current Nanotechnological Strategies for Delivery of Anti-retroviral Drugs: Overview and Future Prospects

Taher, S. S., & Al-Kinani, K. K. (2024) · Current Drug Therapy · doi:10.2174/0115748855331460241017100207 · Cited by 2 · see citing works

Exploring the use of novel drug delivery systems for antiretroviral drugs

Ojewole, E. B., Mackraj, I., Naidoo, P., & Govender, T. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.020 · Cited by 136 · see citing works

New Horizons in Antiretroviral Drug Delivery Systems for HIV Management

dos Santos, K. A., Moreira, L. M. C. D. C., Soares‐Sobrinho, J. L., & Soares, M. F. D. L. R. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673306606240802111136 · Cited by 1 · see citing works

Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them

Sosnik, A., & Augustine, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.022 · Cited by 114 · see citing works